REVIEW ARTICLE
Hypoxia in breast cancer
Submission date: 2014-07-01
Final revision date: 2015-01-07
Acceptance date: 2015-07-05
Publication date: 2016-02-05
Pol J Pathol 2015;66(4):337-346
KEYWORDS
TOPICS
ABSTRACT
Breast cancer continues to be one of the most common malignancies and is a serious problem particularly in women, although men may also be affected. Such lesions are commonly accompanied by hypoxia, and therefore hypoxia-dependent mechanisms, such as overexpression of hypoxia-inducible factor (HIF), the mechanisms are studied as part of the search for a novel method of cancer treatment. Blocking the activity of HIF and HIF-dependent molecular changes raises hopes for identification of a molecular target to inhibit the tumor growth or even to completely prevent its progression. However, this is difficult due to the crucial role HIF plays in numerous processes occurring not only in cancer cells but mostly in healthy systemic cells in physiological conditions.
REFERENCES (49)
1.
Kwasiborski PJ, Kowalczyk P, Mrówka P, et al. Wybrane biochemiczne markery hipoksji. Przegląd Lekarski 2012; 69: 115-119.
2.
Heddleston JM, Li Z, Lathia JD, et al. Hypoxia inducible factors in cancer stem cells. Br J Cancer 2010; 102: 789-795.
3.
Bae MK, Ahn MY, Jeong JW, et al. Jab1 interacts directly with HIF-1alpha and regulates its stability. J Biol Chem 2002; 277: 9-12.
4.
Lee KH, Park JW, Chun YS. Non-hypoxic transcriptional activation of the aryl hydrocarbon receptor nuclear translocator in concert with a novel hypoxia-inducible factor-1alpha isoform. Nucleic Acids Res 2004; 32: 5499-5511.
5.
Lukashev D, Sitkovsky M. Preferential expression of the novel alternative isoform I.3 of hypoxia-inducible factor 1alpha in activated human T lymphocytes. Hum Immunol 2008; 69: 421-425.
6.
Cayre A, Rossignol F, Clottes E, Penault-Llorca F. aHIF but not HIF-1a transcript is a poor prognostic marker in human breast cancer. Breast Cancer Res 2003; 5: R223-R230.
7.
López AJ. Developmental role of transcription factor isoforms generated by alternative spicing. Dev Biol 1995; 172: 396-411.
8.
Dales JP, Beaufils N, Silvy M, et al. Hypoxia inducible facotr 1alpha gene (HIF-1a) splice variants: potential prognostic biomarkers in breast cancer. BMC Med 2010; 8: 44.
9.
Chen HY, Lin YM, Chung HC, et al. miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res 2012; 72: 3631-3641.
10.
Qu A, Du L, Yang Y, et al. Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer. Plos One 2014; 9: e90952.
11.
Szabó DR, Luconi M, Szabó PM, et al. Analysis of circulating microRNAs in adenocortical tumors. Lab Invest 2014; 94: 331-339.
12.
Hong L, Yang J, Han Y, et al. High expression of miR-210 predicts poor survival in patients with breast cancer: a meta-analysis. Gene 2012; 507: 135-138.
13.
Camps C, Buffa FM, Colella S, et al. has-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 2008; 14: 1340-1348.
14.
Foekens JA, Sieuwerts AM, Smid M, et al. Four miRNAs associated with aggressiveness of lymph node – negative, estrogen receptor – positive human breast cancer. Proc Natl Acad Sci U S A 2008; 105: 13021-13026.
15.
Toyama T, Kondo N, Endo Y, et al. High expression of microRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients. Jpn J Clin Oncol 2012; 42: 256-263.
16.
Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5: 343-354.
17.
Filho AL, Lopes JM, Schmitt FC. Angiogenesis and breast cancer. J Oncol 2010; article ID 576384.
18.
Brown JM, Giaccia AJ. The unique physiology of solid tumors:opportunities (and problems) for cancer therapy. Cancer Res 1998; 58: 1408-1416.
19.
Yu S, Zhao T, Guo M, et al. Hypoxic precondictioning up-regulates glucose transport activity and glucise transporter (GLUT1 and GLUT 3) gene expression after acute anoxic exposure in the cultured rat hippocampal neurons and astrocytes. Brain Res 2008; 1221: 22-29.
20.
Peansukmanee S, Vaughan-Thomas A, Carter SD, et al. Effects of hypoxia on glucose transport in primary equine chondrocytes in vitro and evidence of reduced GLUT1 gene expression in pathologic cartilage in vivo. J Orthop Res 2009; 27: 529-535.
21.
Dill RP, Chadan SG, Li C, Parkhouse WS. Aging and glucose transporter plastici in response to hypobaric hypoxia. Mech Ageing Dev 2001; 122: 533-545.
22.
Kimbro KS, Simons JW Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr Relat Cancer 2006; 13: 739-749.
23.
Schindl M, Schoppmann SF, Samonigg H, et al. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 2002; 8: 1831-1837.
24.
Comprehensive molecular portraits of human breast tumors. The cancer genome atlas network. Nature 2012; 490: 61-70.
25.
Burstein HJ, Harris JR, Morrow M. Malignant tumors of the breast. In: DeVita VT, Lawrence TS, Rosenberg SA (eds.). DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9th ed. Lippincott Williams & Wilkins, Philadelphia 2011; 1401-1456.
26.
Edge SB, Byrd DR, Compton CC. AJCC Cancer Staging Manual. 7th ed. Springer, New York 2010; 347-376.
27.
Bos R, van der Groep P, Greijer AE, et al. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 2003; 97: 1573-1581.
28.
De Jong JS, van Diest PJ, Baak JP. Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 2000; 36: 306-312.
29.
Bos R, Zhong H, Hanrahan CF, et al. Levels of hypoxia-inducible factor-1alpha during breast carcinogenesis. J Natl Cancer Inst 2001; 93: 309-314.
30.
Surazynski A, Donald SP, Cooper SK, et al. Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer 2008; 122: 1435-1440.
31.
Surazynski A, Miltyk W, Prokop I, Palka J. The effect of estrogen on prolidase-dependent regulation of HIF-1a expression in breast cancer cells. Mol Cell Biochem 2013; 379: 29-36.
32.
Bos R, van Diest PJ, van der Groep P, et al. Protein expresssion of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer in associated with cyclin D1 and hypoxia-inducible factor 1(HIF-1). Oncogene 2003; 22: 8948-8951.
33.
Gort EH, Groot AJ, Derks van de Ven TL, et al. Hypoxia-inducible factor-1alpha expression requires PI 3-kinase acticvity and correlates witk Akt1 phosphorylation in invasive breast carcinomas. Oncogene 2006; 25: 6123-6127.
34.
Chen J, Imanaka N, Chen J, Griffin JD. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion.
36.
Naldini A, Filippi I, Miglietta D, et al. Interleukin-1b regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1. Eur J Cancer 2010; 46: 3400-3408.
37.
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
38.
Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 2010; 28: 232-239.
39.
Hasebe T, Tsuda H, Hirohashi S, et al. Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients. Breast Cancer Res Treat 1998; 49: 195-208.
40.
Hasebe T, Sasaki S, Imoto S, Ochiai A. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Mod Pathol 2001; 14: 325-337.
41.
Mancino A, Lawrence T. Nuclear factor-B and tumor-associated macrophages. Clin Cancer Res 2010; 16: 784-789.
42.
Tang X. Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. Cancer Lett 2013; 323: 3-10.
43.
Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008; 8: 618-631.
44.
Brown NS, Jones A, Fujiyama C, et al. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res 2000; 60: 6298-6302.
45.
Liu Q, Davidoff O, Niss K, Haase VH. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induces erythropoietis. J Clin Invest 2012; 122: 4635-4644.
46.
Löfstedt T, Jögi A, Sigvartsson M, et al. Induction of ID2 expression by hipoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells. J Biol Chem 2004; 279: 39223-39231.
47.
Jianfang C, Zhenyu D, Yonghai P, et al. HIF-1α inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein. Plos One 2014; 9: e98882.
48.
Jing SW, Wang YD, Chen LQ, et al. Hypoxia suppresses E-cadherin and enhances matrix metalloproteinase-2 expression favoring esophageal carcinoma migration and invasion via hypoxia inducible factor-1 alpha activation. Dis Esophagus 2013; 26: 75-83.
49.
Xin L, Yibin K. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 2010; 16: 5928-5935.
Share
RELATED ARTICLE
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
